Description

Carbamic Acid, [3-Hydroxy-4-(Hydroxymethyl)Cyclopentyl]-, Methyl Ester (9Ci) is a specialized cyclopentane derivative carbamate ester, serving as a key chiral building block and advanced pharmaceutical intermediate. Its value lies in its unique functionalized cyclopentyl structure, which is crucial for synthesizing complex molecules with high stereochemical purity. This compound is primarily needed by research institutions and pharmaceutical manufacturers engaged in the development of novel therapeutics, particularly in antiviral, anticancer, and neurological drug discovery programs.

Application

• Pharmaceutical Intermediate: A critical chiral synthon for the synthesis of nucleoside analogs and other active pharmaceutical ingredients (APIs).
• Antiviral Drug Research: Used in the development of prodrugs and novel compounds targeting viral polymerases and proteases.
• Anticancer Agent Development: Serves as a scaffold for creating targeted kinase inhibitors and other oncology-focused small molecules.
• Neurological Disorder Therapeutics: A building block for compounds aimed at neurological targets, such as enzyme modulators and receptor ligands.
• Process Chemistry & Scale-up: Employed in route scouting and optimization for the commercial manufacturing of complex drugs.
• Asymmetric Synthesis: Utilized as a chiral auxiliary or precursor in stereoselective chemical transformations.

Basic Information

Product Name	Carbamic Acid, [3-Hydroxy-4-(Hydroxymethyl)Cyclopentyl]-, Methyl Ester (9Ci)
CAS No.	688007-24-1
Molecular Formula	C9H15NO4
Molecular Weight	201.22 g/mol
Synonyms	Methyl N-[(1S,2S,3R,4R)-3-Hydroxy-4-(hydroxymethyl)cyclopentyl]carbamate; (1S,2S,3R,4R)-Methyl 3-Hydroxy-4-(hydroxymethyl)cyclopentylcarbamate; (1S,2S,3R,4R)-4-(Hydroxymethyl)cyclopentane-1,2,3-triol 1-Carbamate Methyl Ester; Cyclopentylcarbamate Derivative; Advanced Chiral Cyclopentane Intermediate; Pharmaceutical Intermediate 688007-24-1
EINECS	Contact for details

Quality Control

Our production of Carbamic Acid, [3-Hydroxy-4-(Hydroxymethyl)Cyclopentyl]-, Methyl Ester (9Ci) adheres to stringent quality protocols suitable for pharmaceutical R&D and cGMP manufacturing. Each batch undergoes rigorous analytical testing, including chiral purity verification, to ensure compliance with exacting industry standards. Certificates of Analysis (COA) detailing identity, purity, and impurity profiles are available upon request to support your regulatory and quality assurance requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). This material is hygroscopic (moisture-sensitive) and should be handled under an inert atmosphere when appropriate to prevent degradation.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Chiral Purity (Chiral HPLC)	≥ 99.0% ee
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.